TrueBlue (TBI) Tops Q1 EPS by 8c, Guides Q2 EPS In-Line

TrueBlue (NYSE: TBI) reported Q1 EPS of $0.20, $0.08 better than the analyst estimate of $0.12. Revenue for the quarter came in at $573 million versus the consensus estimate of $561.95 million.

TrueBlue sees Q2 2015 EPS of $0.37-$0.42, versus the consensus of $0.39. TrueBlue sees Q2 2015 revenue of $627-642 million, versus the consensus of $633.32 million.

For earnings history and earnings-related data on TrueBlue (TBI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c